Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis of prospective controlled trials

Background and Aims Diclofenac and indomethacin are the most studied drugs for preventing post-ERCP pancreatitis (PEP). However, there are no prospective, randomized multicenter trials with a sufficient number of patients for correct evaluation of their efficacy. Our aim was to evaluate all prospect...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Gastrointestinal endoscopy 2017-06, Vol.85 (6), p.1144-1156.e1
Hauptverfasser:	Patai, Árpád, MD, PhD, Solymosi, Norbert, PhD, Mohácsi, László, PhD, Patai, Árpád V., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Rectal Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Cholangiopancreatography, Endoscopic Retrograde - adverse effects Controlled Clinical Trials as Topic Diclofenac - therapeutic use Gastroenterology and Hepatology Humans Indomethacin - therapeutic use Pancreatitis - etiology Pancreatitis - prevention & control Postoperative Complications - etiology Postoperative Complications - prevention & control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!